Glenn A. Eisenberg's Insider Trades & SAST Disclosures
Glenn A. Eisenberg's most recent trade in Laboratory Corp. Of America Holdings was a trade of 807 Restricted Stock Unit done . Disclosure was reported to the exchange on Feb. 11, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Glenn A. Eisenberg.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 807 | 2,819 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2025 | 807 | 33,458 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 245.14 per share. | 11 Feb 2025 | 213 | 33,245 (0%) | 0% | 245.1 | 52,215 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 966 | 4,511 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 966 | 32,255 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 885 | 3,626 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2025 | 885 | 32,885 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 247.74 per share. | 06 Feb 2025 | 255 | 32,000 (0%) | 0% | 247.7 | 63,174 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Payment of exercise price or tax liability using portion of securities received from the company at price $ 246.27 per share. | 06 Feb 2025 | 234 | 32,651 (0%) | 0% | 246.3 | 57,627 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Executive Vice President | Sale of securities on an exchange or to another person at price $ 240.43 per share. | 02 Dec 2024 | 11,711 | 31,289 (0%) | 0% | 240.4 | 2,815,651 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn Eisenberg A. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 209.25 per share. | 02 Dec 2024 | 8,923 | 40,212 (0%) | 0% | 209.3 | 1,867,138 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn Eisenberg A. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 8,923 | 0 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | A. Eisenberg Glenn | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 221.67 per share. | 02 Dec 2024 | 2,788 | 43,000 (0%) | 0% | 221.7 | 618,016 | Common Stock |
| Laboratory Corp. Of Americ... | Eisenberg Glenn A. | Executive Vice President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Dec 2024 | 2,788 | 5,577 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 224.55 per share. | 15 Aug 2024 | 9,071 | 31,289 (0%) | 0% | 224.5 | 2,036,882 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 222.65 per share. | 15 Aug 2024 | 2,979 | 43,310 (0%) | 0% | 222.6 | 663,273 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 223.62 per share. | 15 Aug 2024 | 2,950 | 40,360 (0%) | 0% | 223.6 | 659,670 | Common Stock |
| Solventum Corp | Glenn A. Eisenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 3,564 | 3,564 | - | - | Restricted Stock Units | |
| Solventum Corp | Glenn A. Eisenberg | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 May 2024 | 1,980 | 5,544 | - | - | Restricted Stock Units | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 10,229 | 50,785 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 30 Apr 2024 | 10,229 | 0 | - | - | Performance Share Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 201.37 per share. | 30 Apr 2024 | 4,496 | 46,289 (0%) | 0% | 201.4 | 905,360 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 10,229 | 5,477 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Apr 2024 | 10,229 | 45,052 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 203.32 per share. | 15 Apr 2024 | 4,496 | 40,556 (0%) | 0% | 203.3 | 914,127 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 20,033 | 15,706 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Mar 2024 | 20,033 | 43,628 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 216.57 per share. | 27 Mar 2024 | 8,805 | 34,823 (0%) | 0% | 216.6 | 1,906,899 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 215.37 per share. | 21 Feb 2024 | 18,379 | 39,720 (0%) | 0% | 215.4 | 3,958,214 | Common Stock |
| Laboratory Corp. Of Americ... | A. Glenn Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Feb 2024 | 14,054 | 0 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Eisenberg A. Glenn | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 163.63 per share. | 21 Feb 2024 | 14,054 | 58,099 (0%) | 0% | 163.6 | 2,299,656 | Common Stock |
| Laboratory Corp. Of Americ... | A. Eisenberg Glenn | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 215.68 per share. | 21 Feb 2024 | 7,907 | 31,813 (0%) | 0% | 215.7 | 1,705,349 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn Eisenberg A. | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 217.52 per share. | 21 Feb 2024 | 6,665 | 25,148 (0%) | 0% | 217.5 | 1,449,774 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 217.98 per share. | 21 Feb 2024 | 1,553 | 23,595 (0%) | 0% | 218.0 | 338,529 | Common Stock |
| Laboratory Corp. Of Americ... | A. Glenn Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 807 | 44,260 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Eisenberg Glenn A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2024 | 807 | 35,739 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 227.45 per share. | 11 Feb 2024 | 215 | 44,045 (0%) | 0% | 227.5 | 48,902 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn Eisenberg A. | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 9,000 | 9,000 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Eisenberg A. Glenn | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2024 | 2,900 | 37,431 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Eisenberg Glenn A. | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 885 | 43,689 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Feb 2024 | 885 | 36,546 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 223.71 per share. | 06 Feb 2024 | 236 | 43,453 (0%) | 0% | 223.7 | 52,796 | Common Stock |
| Laboratory Corp. Of Americ... | A. Glenn Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 856 | 34,531 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Eisenberg A. Glenn | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2024 | 856 | 43,032 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn Eisenberg A. | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 221.54 per share. | 02 Feb 2024 | 228 | 42,804 (0%) | 0% | 221.5 | 50,511 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Jun 2023 | 20,193 | 33,957 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 30 Mar 2023 | 11,715 | 47,355 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 224.70 per share. | 30 Mar 2023 | 5,179 | 42,176 (0%) | 0% | 224.7 | 1,163,721 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 723 | 35,835 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2023 | 723 | 13,764 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 248.13 per share. | 11 Feb 2023 | 195 | 35,640 (0%) | 0% | 248.1 | 48,385 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 7,500 | 7,500 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Feb 2023 | 2,380 | 14,487 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 970 | 35,373 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2023 | 970 | 12,107 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 244.50 per share. | 04 Feb 2023 | 261 | 35,112 (0%) | 0% | 244.5 | 63,815 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 767 | 34,609 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2023 | 767 | 13,077 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 254.99 per share. | 02 Feb 2023 | 206 | 34,403 (0%) | 0% | 255.0 | 52,528 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 12,032 | 13,844 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 12,032 | 39,190 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 9,170 | 9,170 | - | - | Performance Share Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2022 | 9,170 | 25,876 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 222.56 per share. | 01 Nov 2022 | 5,348 | 33,842 (0%) | 0% | 222.6 | 1,190,251 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 211.13 per share. | 26 Sep 2022 | 11,699 | 29,988 (0%) | 0% | 211.1 | 2,470,064 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 209.29 per share. | 26 Sep 2022 | 5,627 | 46,531 (0%) | 0% | 209.3 | 1,177,697 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 210.21 per share. | 26 Sep 2022 | 4,844 | 41,687 (0%) | 0% | 210.2 | 1,018,242 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 211.86 per share. | 26 Sep 2022 | 2,830 | 27,158 (0%) | 0% | 211.9 | 599,573 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 254.26 per share. | 03 Aug 2022 | 19,338 | 53,658 (0%) | 0% | 254.3 | 4,916,861 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 11,600 | 0 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 146.59 per share. | 03 Aug 2022 | 11,600 | 84,258 (0%) | 0% | 146.6 | 1,700,444 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 130.60 per share. | 03 Aug 2022 | 11,400 | 63,558 (0%) | 0% | 130.6 | 1,488,840 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 11,400 | 0 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 253.26 per share. | 03 Aug 2022 | 11,262 | 72,996 (0%) | 0% | 253.3 | 2,852,270 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2022 | 9,100 | 0 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 168.49 per share. | 03 Aug 2022 | 9,100 | 72,658 (0%) | 0% | 168.5 | 1,533,259 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Sale of securities on an exchange or to another person at price $ 254.88 per share. | 03 Aug 2022 | 1,500 | 52,158 (0%) | 0% | 254.9 | 382,319 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2022 | 14,144 | 58,444 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 276.42 per share. | 27 Mar 2022 | 6,286 | 52,158 (0%) | 0% | 276.4 | 1,737,576 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 7,700 | 7,700 | - | - | Non-qualified Stock Options | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Feb 2022 | 2,170 | 17,646 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 940 | 44,577 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 11 Feb 2022 | 940 | 16,706 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 272.68 per share. | 11 Feb 2022 | 277 | 44,300 (0%) | 0% | 272.7 | 75,532 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 970 | 15,476 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Feb 2022 | 970 | 43,923 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 277.48 per share. | 04 Feb 2022 | 286 | 43,637 (0%) | 0% | 277.5 | 79,359 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 766 | 16,446 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2022 | 766 | 43,189 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 273.18 per share. | 02 Feb 2022 | 236 | 42,953 (0%) | 0% | 273.2 | 64,470 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 9,024 | 17,212 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 9,024 | 46,457 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 288.78 per share. | 01 Nov 2021 | 4,034 | 42,423 (0%) | 0% | 288.8 | 1,164,939 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Mar 2021 | 8,042 | 41,028 (0%) | 0% | 0 | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 251.58 per share. | 27 Mar 2021 | 3,595 | 37,433 (0%) | 0% | 251.6 | 904,430 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 940 | 33,266 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 940 | 26,236 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 780 | 32,558 (0%) | 0% | - | Common Stock | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 12 Feb 2021 | 780 | 27,176 | - | - | Restricted Stock Unit | |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 280 | 32,986 (0%) | 0% | 238.3 | 66,713 | Common Stock |
| Laboratory Corp. Of Americ... | Glenn A. Eisenberg | Chief Financial Officer, EVP | Payment of exercise price or tax liability using portion of securities received from the company at price $ 238.26 per share. | 12 Feb 2021 | 232 | 32,326 (0%) | 0% | 238.3 | 55,276 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges